Neuroprotection in early stages of Alzheimers Disease is promoted by Transthyretin angiogenic properties
Tiago Gião, Joana Saavedra, José Ricardo Vieira, Marta Teixeira Pinto, Gemma Arsequell, Isabel Cardoso
This study shows that transthyretin (TTR) promotes angiogenesis and vascular health in Alzheimer's disease, with tetrameric stabilization offering a potential therapeutic strategy.
Alzheimer s Research & Therapy · Aug 24, 2021Peer-reviewedMolecular Biology